To read more about the items below, click above for a PDF of the newsletter.
- The First Amendment protects the truthful, non-misleading advertising of alcoholic beverages. (Missouri Broadcasters Association v. Taylor)
- The federal government may not compel drug manufacturers to list prices in their advertising. (In Re: Regulation to Require Drug-Price Transparency)
- Antitrust liability under a refusal-to-deal theory should be narrowly construed. (Viamedia v. Comcast)
- The federal courts should adhere to congressional limitations on venue for patent-infringement lawsuits. (Erfindergemeinschaft UroPep GbR v. Eli Lilly and Co.)
- U.S. Court of Appeals for the District of Columbia Circuit refuses to enforce an NLRB ruling under which a company was deemed a “joint employer” of its independent contractor’s employees. (Browning-Ferris Industries of California, Inc. v. NLRB)
- FDA withdraws 2013 proposed labeling-change rule that would have exposed generic drug makers to increased product liability. (In Re: Proposed Labeling Changes for Approved Drugs)